What does Harmony Biosciences Holdings, Inc. do?

Jun 22 2025 06:59 PM IST
share
Share Via
Harmony Biosciences Holdings, Inc. is a pharmaceutical company specializing in therapies for central nervous system disorders, particularly narcolepsy. As of March 2025, it reported net sales of $185 million and a net profit of $46 million, with a market cap of approximately $1.86 billion.
Overview:
Harmony Biosciences Holdings, Inc. is a pharmaceutical company focused on therapies for patients suffering from central nervous system disorders, particularly narcolepsy, and operates within the Pharmaceuticals & Biotechnology industry in the small-cap market.

Financial Snapshot:
- Most recent Net Sales: 185 Million (Quarterly Results - Mar 2025)
- Most recent Net Profit: 46 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 1,864.57 Million (Small Cap)

Key Metrics:
- P/E: 13.00
- Dividend Yield: 0.00%
- Debt Equity: -0.42
- Return on Equity: 21.20%
- Price to Book: 2.59

Contact Details:
- Address: 630 W Germantown Pike, Suite 215, PLYMOUTH MEETING PA: 19462
- Tel: 1 484 5399800
- Fax: 1 302 6555049
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News